Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.

Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, Canonica GW, Passalacqua G.

J Allergy Clin Immunol. 2007 Jul;120(1):164-70. Epub 2007 Jun 1.

PMID:
17543376
3.

Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.

Galli E, Chini L, Nardi S, Benincori N, Panei P, Fraioli G, Moschese V, Rossi P.

Allergol Immunopathol (Madr). 1994 Jan-Feb;22(1):18-22.

PMID:
8030579
4.

[Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].

Silny W, Czarnecka-Operacz M.

Pol Merkur Lekarski. 2006 Dec;21(126):558-65. Polish.

PMID:
17405298
5.
6.
7.

Allergen-antibody complexes in the treatment of atopic dermatitis: preliminary results of a double-blind placebo-controlled study.

Leroy BP, Boden G, Jacquemin MG, Lachapelle JM, Saint-Remy JM.

Acta Derm Venereol Suppl (Stockh). 1992;176:129-31.

PMID:
1476025
8.

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.

García-Robaina JC, Sánchez I, de la Torre F, Fernández-Caldas E, Casanovas M.

J Allergy Clin Immunol. 2006 Nov;118(5):1026-32. Epub 2006 Sep 18.

PMID:
17088125
9.

Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients.

Basomba A, Tabar AI, de Rojas DH, García BE, Alamar R, Olaguíbel JM, del Prado JM, Martín S, Rico P.

J Allergy Clin Immunol. 2002 Jun;109(6):943-8.

PMID:
12063522
10.

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.

Bahçeciler NN, Işik U, Barlan IB, Başaran MM.

Pediatr Pulmonol. 2001 Jul;32(1):49-55.

PMID:
11416876
11.

Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study.

Oosting AJ, de Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, de Monchy JG, van Wijk RG, Bruijnzeel-Koomen CA.

J Allergy Clin Immunol. 2002 Sep;110(3):500-6.

PMID:
12209102
12.

A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study.

Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM.

J Am Acad Dermatol. 1993 Feb;28(2 Pt 1):232-9.

PMID:
8432921
14.
15.
16.

[The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].

Pacor ML, Biasi D, Maleknia T.

Recenti Prog Med. 1994 May;85(5):273-7. Italian.

PMID:
8023005
17.

Clinical and immunologic evaluation of tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial.

Pauli G, Bessot JC, Bigot H, Delaume G, Hordle DA, Hirth C, Thierry R.

J Allergy Clin Immunol. 1984 Oct;74(4 Pt 1):524-35.

PMID:
6208231
18.

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

Giovane AL, Bardare M, Passalacqua G, Ruffoni S, Scordamaglia A, Ghezzi E, Canonica GW.

Clin Exp Allergy. 1994 Jan;24(1):53-9.

PMID:
8156447
19.
20.

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.

Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A.

Allergy. 2006 Feb;61(2):202-5.

Supplemental Content

Support Center